Literature DB >> 21307729

Is early venous thromboembolism prophylaxis safe in trauma patients with intracranial hemorrhage.

Daniel M Koehler1, Jason Shipman, Mario A Davidson, Oscar Guillamondegui.   

Abstract

BACKGROUND: Patients with traumatic brain injuries (TBIs) are at high risk for venous thromboembolic sequelae; however, prophylaxis is often delayed because of the perceived risk of intracranial hemorrhagic exacerbation. The goal of this study was to determine whether enoxaparin for early venous thromboembolism (VTE) prophylaxis is safe for hemodynamically stable patients with TBIs.
METHODS: This is a retrospective cohort study from a Level I Trauma Center of patients with TBIs receiving early (0-72 hours) or late (>72 hours) VTE prophylaxis. Inclusion criteria included evidence of acute intracranial hemorrhagic injury (IHI) on admission computed tomography, head/neck abbreviated injury score≥3, age≥16 years, and hospital length of stay≥72 hours. Exclusion criteria included intracranial pressure monitor/ventriculostomy, current systemic anticoagulation, pregnancy, coagulopathy, history of DVT, ongoing intra-abdominal hemorrhage 24 hours postadmission, and preexisting inferior vena cava filter. Progression of IHI defined as lesion expansion/new IHI on repeat computed tomography.
RESULTS: Totally, 669 patients were identified: 268 early (40.1%) and 401 late (59.9%), with a mean injury severity score of 27.8±10.2 and 29.4±11, respectively. Head neck abbreviated injury score of 3 (47% vs. 34%), 4 (42% vs. 46%), 5 (11% vs. 19%), and 6 (0% vs. 1%) were reported for the early and late treatment groups, respectively. Mean time to prophylaxis was 2.77 days±0.49 days and 5.31 days±1.97 days. IHI progression before prophylaxis was 9.38% versus 17.41% (p<0.001) and after prophylaxis was 1.46% versus 1.54% (p>0.9). Proportions of proximal DVT were 1.5% versus 3.5% (p=0.117) and pulmonary embolism were 1.5% versus 2.2% (p=0.49). There were no differences in injury severity score, age, and pelvic and/or long bone fractures.
CONCLUSIONS: We found no evidence that early VTE prophylaxis increases the rate of IHI progression in hemodynamically stable patients with TBIs. The natural rate of IHI progression observed is comparable with previous studies. Although not powered to detect differences in the incidence of DVT and pulmonary embolism, the data trend toward increased proportions of both VTE outcomes in the late group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307729     DOI: 10.1097/TA.0b013e31820b5d22

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  21 in total

1.  Safety of Chemical DVT Prophylaxis in Severe Traumatic Brain Injury with Invasive Monitoring Devices.

Authors:  Bradley A Dengler; Paolo Mendez-Gomez; Amanda Chavez; Lacey Avila; Joel Michalek; Brian Hernandez; Ramesh Grandhi; Ali Seifi
Journal:  Neurocrit Care       Date:  2016-10       Impact factor: 3.210

2.  Dynamic coagulability after injury: Is delaying venous thromboembolism chemoprophylaxis worth the wait?

Authors:  Joshua J Sumislawski; Lucy Z Kornblith; Amanda S Conroy; Rachael A Callcut; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2018-11       Impact factor: 3.313

3.  Safety of a DVT chemoprophylaxis protocol following traumatic brain injury: a single center quality improvement initiative.

Authors:  Christopher M Nickele; Timothy K Kamps; Joshua E Medow
Journal:  Neurocrit Care       Date:  2013-04       Impact factor: 3.210

4.  Inferior vena cava filters for primary prophylaxis: when are they indicated?

Authors:  Eric Wehrenberg-Klee; S William Stavropoulos
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

Review 5.  A Systematic Review of the Benefits and Risks of Anticoagulation Following Traumatic Brain Injury.

Authors:  Xian Shen; Sarah K Dutcher; Jacqueline Palmer; Xinggang Liu; Zippora Kiptanui; Bilal Khokhar; Mohammad H Al-Jawadi; Yue Zhu; Ilene H Zuckerman
Journal:  J Head Trauma Rehabil       Date:  2015 Jul-Aug       Impact factor: 2.710

6.  Venous thromboembolism prophylaxis and the impact of a thrombosis service at a Canadian level 1 trauma centre

Authors:  Paul T. Engels; Heather Thomas; Angela Coates; Husham Bakry; Abdulaziz Alali; Ahmad AlGhambdi; Ahmed Al-Jabri; Ahmed Bugshan
Journal:  Can J Surg       Date:  2019-12-01       Impact factor: 2.089

7.  The Formation of Microthrombi in Parenchymal Microvessels after Traumatic Brain Injury Is Independent of Coagulation Factor XI.

Authors:  Susanne M Schwarzmaier; Ciaran de Chaumont; Matilde Balbi; Nicole A Terpolilli; Christoph Kleinschnitz; Andras Gruber; Nikolaus Plesnila
Journal:  J Neurotrauma       Date:  2016-02-17       Impact factor: 5.269

8.  Benefits and risks of anticoagulation resumption following traumatic brain injury.

Authors:  Jennifer S Albrecht; Xinggang Liu; Mona Baumgarten; Patricia Langenberg; Gail B Rattinger; Gordon S Smith; Steven R Gambert; Stephen S Gottlieb; Ilene H Zuckerman
Journal:  JAMA Intern Med       Date:  2014-08       Impact factor: 21.873

9.  The Parkland Protocol's modified Berne-Norwood criteria predict two tiers of risk for traumatic brain injury progression.

Authors:  Rachel A Pastorek; Michael W Cripps; Ira H Bernstein; William W Scott; Christopher J Madden; Kim L Rickert; Steven E Wolf; Herb A Phelan
Journal:  J Neurotrauma       Date:  2014-08-28       Impact factor: 5.269

10.  Symptomatic venous thromboembolism in Asian major trauma patients: incidence, presentation and risk factors.

Authors:  T H Wong; M P Koh; J Ng
Journal:  Eur J Trauma Emerg Surg       Date:  2013-04-25       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.